Oestrogen Receptor Analysis of Paraffin Sections and Cytosol Samples of Primary Breast Cancer in Relation to Outcome After Adjuvant Tamoxifen Treatment

References

• Early Breast Cancer Trialist' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1–15; 71–85
   PubMedGoogle Scholar
• Rose C, Thorpe S, Andersen K, et al. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1985; 1: 16–9
   PubMed Web of Science ®Google Scholar
• Rutqvist L, Cedemark B, Glas U, et al. The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect. Breast Cancer Res Treat 1987; 10: 255–66
   PubMed Web of Science ®Google Scholar
• Rydén S, Fernö M, Borg Å, Hafström Lo, Möller T, Norgren A. Prognostic significance of estrogen and progesterone receptors in stage II breast cancer. J Surg Oncol 1988; 37: 221–6
   PubMed Web of Science ®Google Scholar
• Baum M. Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. Analysis at eight years by Nolvadex Adjuvant Trial Organisation. Br J Cancer 1988; 57: 608–11
   PubMed Web of Science ®Google Scholar
• Miller R, Hapke M, Greene G. Immunocytochemical assay for estrogen receptor with monoclonal antibody D753Pγ in routinely processed formaldehyde-fixed breast tissue. Cancer 1993; 71: 3541–6
   PubMed Web of Science ®Google Scholar
• Briscoe D, Ni K, Wied G, et al. Comparison of estrogen receptor immunocytochemical assay in frozen and paraffin sections. Anal Quant Cytol Histol 1992; 14: 105–12
   PubMedGoogle Scholar
• Andersen J, Örntoft T, Skovgaard Poulsen H. Semiquantita-tive oestrogen receptor assay in formalin-fixed paraffin sections of human breast cancer tissue using monoclonal antibodies. Br J Cancer 1986; 53: 691–4
   PubMed Web of Science ®Google Scholar
• Aasmundstad T, Haugen O, Johannesen E, Höe A, Kvinnsland S. Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods. J Clin Pathol 1992; 45: 125–9
   PubMed Web of Science ®Google Scholar
• Shimada A, Kimura S, Abe K, et al. Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections. Proc Natl Acad Sci 1985; 82: 4803–47
   PubMed Web of Science ®Google Scholar
• Cohen C, Unger E R, Sgoutas D, Chenggis Bradley N. Automated immunohistochemical estrogen receptor in fixed embedded breast carcinomas. Comparison with manual immunohistochemistry on frozen tissue. Am J Clin Pathol 1989; 92: 669–72
   PubMed Web of Science ®Google Scholar
• Andersen J, Thorpe S, King W, et al. The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays. Eur J Cancer 1990; 26: 442–9
   PubMed Web of Science ®Google Scholar
• Saati T, Clamens S, Cohen-Knafo E, et al. Production of monoclonal antibodies to human estrogen receptor protein (ER) using recombinant ER (RER). Int J Cancer 1993; 55: 651–4
   PubMed Web of Science ®Google Scholar
• Sannino P, Shousa S. Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing. J Clin Pathol 1994; 47: 90–2
   PubMed Web of Science ®Google Scholar
• Shi S-R, Key M, Kalra K. Antigen retrival in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741–8
   PubMed Web of Science ®Google Scholar
• Heubner A, Beck T, Grill H-J, Pollow K. Comparison of immunocytochemical estrogen receptor assay, estrogen receptor enzyme immunoassay, and radioligand-labelled estrogen receptor assay in human breast cancer and uterine tissue. Cancer Res 1986; 46: 4191s–5s
   Web of Science ®Google Scholar
• Fernö M, Borg Å, Norgren A. A comparison of two steroid receptor assays in breast cancer: dextran coated charcoal and isoelectric focusing. Anticancer Res 1983; 3: 243–6
   PubMed Web of Science ®Google Scholar
• Fernö M, Borg Å, Sellberg G. Enzyme immuno assay of the estrogen receptor in breast cancer biospy samples. A comparison with isoelectric focusing. Acta Radiol Oncol 1986; 25: 171–5
   PubMed Web of Science ®Google Scholar
• Sigurdsson H, Baldetorp B, Borg Å, et al. Indicator of prognosis in node-negative breast cancer. N Engl J Med 1990; 322: 1045–53
   PubMed Web of Science ®Google Scholar
• Fernö M, Borg Å, Johansson U. Estrogen and progesterone receptor analysis in more than 4 000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Acta Oncol 1990; 29: 129–35
   PubMed Web of Science ®Google Scholar
• Baldetorp B, Dalberg M, Hoist U, Lindgren G. Statistical evaluation of cell kinetic data from DNA flow cyto-metry (FCM) by the EM algorithm. Cytometry 1989; 10: 695–705
   PubMedGoogle Scholar
• Hiddemann W, Schumann J, Andreef M, et al. Convention on nomenclature for DNA cytometry. Cytometry 1984; 5: 445–6
   Google Scholar
• Baisch H, Gohde W, Linden W A. Analysis of PCP-data to determine the fraction of cells in various phases of cell cycle. Rad Environm Biophys 1975; 12: 31–9
   PubMed Web of Science ®Google Scholar
• Fernö M, Baldetorp B, Borg Å, Olson H, Sigurdsson H, Killander. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncologica 1992; 31: 157–65
   PubMed Web of Science ®Google Scholar
• Elston C. Grading of invasive carcinoma of the breast. Diagnostic histopathology of the breast, D Page, T Anderson. Churchill Livingstone, Edinburgh 1987; 300–11
   Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–170
   PubMedGoogle Scholar
• Fisher E, Redmond C, Liuh H, Rochette H, Fisher B. Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer. Cancer 1980; 45: 349–53
   PubMed Web of Science ®Google Scholar
• McCarty K, Szabo E, Flowers J, et al. Use of monoclonal anti-estrogen receptor antibody in the immunohistochemical evalution of human tumors. Cancer Res (suppl) 1986; 46(suppl)4244–8
   Google Scholar